Abstract：
:A persistent obstacle in the use of vector systems for gene therapy has been the inability to attain high-level expression of the target gene in primary cells in vivo. The MFG retroviral vector was designed to yield improved expression over the widely used N2 or LN vectors; however, the molecular basis for this effect has not been examined. Using the human glucocerebrosidase (GC) enzyme as a reporter, we compared expression from the MFG and N2 vector backbones in transduced murine hematopoietic cells after syngeneic bone marrow transplantation. Reporter enzyme activities in primary spleen colonies of transplanted mice were seven-fold higher per vector copy in cells transduced with the (MFG-based) MGC vector than in cells bearing the (N2-based) G2 vector. In spleen colonies harboring the MGC vector, the ratio of spliced to unspliced vector RNA was increased four-fold relative to the G2 vector transcripts in Northern blot analyses. Further analyses indicated that MGC-transduced cells contained five-fold higher levels of spliced RNA per vector copy. Since translation of spliced RNA species (in which the complex secondary structure of the packaging signal has been excised) is likely to proceed with enhanced efficiency, the augmented levels of spliced RNA produced by MFG may represent the key element of increased protein expression from this vector. These findings suggest that the MFG retroviral vector may provide higher level expression of target genes used in human gene therapy.
journal_name
Gene Therjournal_title
Gene therapyauthors
Krall WJ,Skelton DC,Yu XJ,Riviere I,Lehn P,Mulligan RC,Kohn DBsubject
Has Abstractpub_date
1996-01-01 00:00:00pages
37-48issue
1eissn
0969-7128issn
1476-5462journal_volume
3pub_type
杂志文章相关文献
GENE THERAPY文献大全abstract：:Recombinant adenoviruses (Ad) are attractive vectors for gene transfer in vitro and in vivo. However, the widely used E1-deleted vectors as well as newer generation vectors contain viral sequences, including transcriptional elements for viral gene expression. These viral regulatory elements can interfere with heterolo...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301139
更新日期：2000-04-01 00:00:00
abstract：:Virus-directed enzyme prodrug therapy utilizing the bacterial enzyme nitroreductase delivered by a replication-defective adenovirus vector to activate the prodrug CB1954 is a promising strategy currently undergoing clinical trials in patients with a range of cancers. Similarly, selectively replicating oncolytic adenov...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302510
更新日期：2005-08-01 00:00:00
abstract：:We have developed a retroviral vector coexpressing the multidrug-resistance 1 (MDR1) cDNA for inducing cancer drug resistance and the truncated version of the low-affinity nerve growth factor receptor (DeltaLNGFR) for cell-surface marking of transduced cells. The vector is based on the FMEV backbone which mediates hig...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300942
更新日期：1999-07-01 00:00:00
abstract：:The efficient delivery of genetic material to the developing fetal brain represents a powerful research tool and a means to supply therapy in a number of neonatal lethal neurological disorders. In this study, we have delivered vectors based upon adenovirus serotype 5 (Ad5) and adeno-associated virus (AAV) pseudotypes ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2011.157
更新日期：2012-09-01 00:00:00
abstract：:Hypoxia initiates an adaptive physiological response in all organisms and plays a role in the pathogenesis of several human diseases. The hypoxia/HIF-inducible factor-1 (HIF-1) transcription factor mediates transcriptional responses to hypoxia by binding to a cis-acting hypoxia-responsive element (HRE) present within ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301605
更新日期：2001-12-01 00:00:00
abstract：:Cancer therapies that target a single protein or pathway may be limited by their specificity, thus missing key players that control cellular proliferation and contributing to the failure of the treatment. We propose that approaches to cancer therapy that hit multiple targets would limit the chances of escape. To this ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/s41434-019-0096-1
更新日期：2020-02-01 00:00:00
abstract：:A simple, efficient and reproducible method to transduce proteins into mammalian cells has not been established. Here we describe a novel protein transduction method based on a lentiviral vector. We have developed a method to package several thousand foreign protein molecules into a lentivirus-like nanoparticle (LENA)...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2011.38
更新日期：2011-09-01 00:00:00
abstract：:Gene modification of malignant cells to express immune stimulators (cytokines and immune costimulators) has provided the basis for a novel form of immunotherapy. Using a MPSV-based retroviral vector with hygromycin resistance gene as a selectable marker, we have studied retrovirus-mediated gene transfer of an immune c...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300437
更新日期：1997-07-01 00:00:00
abstract：:Rhesus macaque tripartite motif (TRIM)5alpha potently inhibits early stages of human immunodeficiency virus (HIV)-1 replication, while the human orthologue has little effect on this virus. We used PCR-based random mutagenesis to construct a large library of human TRIM5alpha variants containing mutations in the PRYSPRY...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2010.40
更新日期：2010-07-01 00:00:00
abstract：:Adoptive immunotherapy of cancer using chimeric antigen receptor (CAR)-engineered T cells with redirected specificity showed efficacy in recent trials. In preclinical models, 'second-generation' CARs with CD28 costimulatory domain in addition to CD3ζ performed superior in redirecting T-cell effector functions and surv...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2010.127
更新日期：2011-01-01 00:00:00
abstract：:We have developed a novel immunostimulatory molecule against tumor cells, composed of an anti-FcgammaRIII (CD16) scFv fused to the platelet-derived growth factor receptor (PDGFR) transmembrane region. This fusion molecule was stably expressed on the tumor cell surface and retained the ability of the parental antibody ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301575
更新日期：2001-11-01 00:00:00
abstract：:Genetic modification of tumor cells with the gene for the B7.1 or with the genes for cytokines results in increased tumor cell immunogenicity. In the work reported here, immunization of naive animals with either B7.1 or gamma-IFN gene-modified MCA106 tumor cells effectively protects the host from subsequent challenge ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3300820
更新日期：1999-02-01 00:00:00
abstract：:Cell surface targeting of recombinant adeno-associated virus (rAAV) vectors is an attractive strategy to modify AAV's natural tropism. As modification of the capsid surface is likely to affect the mechanism of vector internalization and consequently the vector's intracellular fate, we investigated early steps in cell ...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2011.78
更新日期：2012-02-01 00:00:00
abstract：:Advanced prostate cancer (PC) still remains incurable. Novel immunogene therapy shows promise as treatment strategy that can target both localized and metastasized PC. In this study, we have developed a PC-specific oncolytic adenovirus (Ad-PL-PPT-E1A) armed with fusion gene of prostate-specific antigen and CD40 ligand...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2014.46
更新日期：2014-08-01 00:00:00
abstract：:Production of retroviral vectors for clinical use requires removal of cells and cellular debris. We combined a series of filters of decreasing pore size using commercially available blood banking filters approved for clinical use. The collection bag and filters can be connected to create a sterile, closed system using...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301328
更新日期：2000-12-01 00:00:00
abstract：:We have developed synthetic double-stranded oligodeoxynucleotides (ODN) as 'decoy' cis elements that block the binding of nuclear factors to promoter regions of targeted genes, resulting in the inhibition of gene transactivation in vivo. In the present study, we employed decoy ODN targeting the transcription factor nu...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301478
更新日期：2001-06-01 00:00:00
abstract：:Selection of targeted vectors from virus display peptide libraries is a versatile and efficient approach to improve vector specificity and efficiency. This strategy has been used to target various cell types in vitro. Here, we report the screening of an adeno-associated virus type 2 (AAV2) display peptide library in v...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2010.44
更新日期：2010-08-01 00:00:00
abstract：:Recently, there has been an increasing level of interest in electroporation for gene delivery due to the site-specific nature of the delivery, as well as the high efficiency of the method. Electroporation involves the application of a pulsed electric field to cells to enhance cell permeability, resulting in the transi...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301733
更新日期：2002-08-01 00:00:00
abstract：:Mutations in GJB2, which codes for the gap junction (GJ) protein connexin26 (Cx26), are the most common causes of human nonsyndromic hereditary deafness. We inoculated modified adeno-associated viral (AAV) vectors into the scala media of early postnatal conditional Gjb2 knockout mice to drive exogenous Cx26 expression...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2013.59
更新日期：2014-01-01 00:00:00
abstract：:Dendritic cell (DC)-based vaccines have been applied clinically in the setting of advanced-stage cancer. To date, the clinical efficacy of these vaccines has been limited, possibly owing to the impairment of transferred DC function in cancer-bearing patients. In this study, we examined the therapeutic efficacy of inte...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3302941
更新日期：2007-06-01 00:00:00
abstract：:Direct gene transfer for the treatment of human diseases requires a vector which can be administered efficiently, safely and repeatedly. Cationic liposomes represent one of the few examples that can meet these requirements. Currently, more than a dozen cationic liposome formulations have been reported. These liposomes...
journal_title：Gene therapy
pub_type： 杂志文章,评审
doi：
更新日期：1995-12-01 00:00:00
abstract：:For certain gene therapy applications, the simultaneous delivery of multiple genes would allow for novel therapies. In the case of adeno-associated virus (AAV) vectors, the limited packaging capacity greatly restricts current methods of carrying multiple transgene cassettes. To address this issue, a recombinant AAV (r...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2009.106
更新日期：2009-11-01 00:00:00
abstract：:Replication-deficient retroviruses have been successfully utilized as vectors, offering an efficient, stable method of therapeutic gene delivery. Many examples exist proving this mode of integrative gene transfer is both effective and safe in cultured systems and clinical trials. Along with their success, severe side ...
journal_title：Gene therapy
pub_type： 杂志文章,评审
doi：10.1038/gt.2012.88
更新日期：2013-06-01 00:00:00
abstract：:Intervertebral disc degeneration (IVDD) is a multi-factorial process characterized by phenotypic and genotypic changes, which leads to low back pain and disability. Prolonged imbalance between anabolism and catabolism in discs alters their composition resulting in progressive loss of proteoglycans and hydration leadin...
journal_title：Gene therapy
pub_type： 信件,评审
doi：10.1038/s41434-018-0004-0
更新日期：2018-04-01 00:00:00
abstract：:Therapeutic RNA interference (RNAi) has emerged as a promising approach for the treatment of many incurable diseases, including cancer, infectious disease or neurodegenerative disorders. Demonstration of efficacy and safety in animal models is necessary before planning human application. Our group and others have prev...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2011.10
更新日期：2011-07-01 00:00:00
abstract：:Gene transfer technology has opened novel treatment avenues toward the treatment of damaged musculoskeletal tissues, and may be particularly beneficial to articular cartilage. There is no natural repair mechanism to heal damaged or diseased cartilage. Existing pharmacologic, surgical and cell based treatments may offe...
journal_title：Gene therapy
pub_type： 杂志文章,评审
doi：10.1038/sj.gt.3302201
更新日期：2004-02-01 00:00:00
abstract：:We tested the longevity of gene expression provided by autonomously replicating vectors. The vectors contain segments of human genomic DNA that provide efficient replication initiation and sequences derived from Epstein-Barr virus that provide nuclear retention. In order to monitor gene expression, the vectors also ca...
journal_title：Gene therapy
pub_type： 杂志文章
doi：
更新日期：1996-06-01 00:00:00
abstract：:The recent surge of DNA sequence information resulting from the efforts of agencies interested in deciphering the human genetic code has facilitated technological developments that have been critical in the identification of genes associated with numerous disease pathologies. In addition, these efforts have opened the...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/sj.gt.3301740
更新日期：2002-06-01 00:00:00
abstract：:Integration site analysis was performed on six dogs with canine leukocyte adhesion deficiency (CLAD) that survived greater than 1 year after infusion of autologous CD34+ bone marrow cells transduced with a gammaretroviral vector expressing canine CD18. A total of 387 retroviral insertion sites (RIS) were identified in...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2008.52
更新日期：2008-07-01 00:00:00
abstract：:Tissue-specific promoters for gene therapy are typically too big for adeno-associated virus (AAV) vectors; thus, the exploration of small effective non-viral regulatory elements is of particular interest. Wild-type AAV can specifically integrate into a region on human chromosome 19 termed AAVS1. Earlier work has deter...
journal_title：Gene therapy
pub_type： 杂志文章
doi：10.1038/gt.2008.134
更新日期：2009-01-01 00:00:00
